# Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis

Study · id `cardio:ct-nct03342807` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03342807](<https://clinicaltrials.gov/study/NCT03342807>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03342807

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

## Technical summary

Registry record NCT03342807. Non-randomized; no masking; primary purpose treatment. Start 2017-11 (anticipated); primary completion 2019-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT03342807, source copy `cardio:ctgov-nct03342807-2017-11-17`, retrieved 2026-10-31)
- Planned start: 2017-11 (anticipated) (ClinicalTrials.gov record NCT03342807, source copy `cardio:ctgov-nct03342807-2017-11-17`, retrieved 2026-10-31)
- Primary completion: 2019-11 (anticipated) (ClinicalTrials.gov record NCT03342807, source copy `cardio:ctgov-nct03342807-2017-11-17`, retrieved 2026-10-31)
- Completion: 2020-11 (anticipated) (ClinicalTrials.gov record NCT03342807, source copy `cardio:ctgov-nct03342807-2017-11-17`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03342807-2017-11-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis
- Condition: Pancreatitis, Acute
- Condition: Hypertriglyceridemia
- Intervention (Drug): Insulin
- Intervention (Device): Aphesis
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER
- Collaborator: First Hospitals affiliated to the China PLA General Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: Nanjing General Hospital
- Collaborator class: UNKNOWN
- Collaborator: Fujian Provincial Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital, Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: Jinhua Central Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial Hospital of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Kunming Medical University
- Collaborator class: OTHER
- Collaborator: Tianjin Medical University General Hospital
- Collaborator class: OTHER
- Collaborator: The First Hospital of Hebei Medical College
- Collaborator class: UNKNOWN
- Collaborator: The First Affiliated Hospital with Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: Shenzhen Baoan District People's Hospital
- Collaborator class: OTHER
- Collaborator: General Hospital of Shenyang Military Region
- Collaborator class: OTHER
- Collaborator: Cangzhou Center Hospital
- Collaborator class: UNKNOWN
- Collaborator: Wuxi Third People 's Hospital
- Collaborator class: UNKNOWN
- Collaborator: General Hospital of Ningxia Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)
- Registry lists this organization as a collaborator: Fujian Provincial Hospital (`cardio:org-fujian-provincial-hospital`)
- Registry lists this organization as a collaborator: First Affiliated Hospital, Sun Yat-Sen University (`cardio:org-first-affiliated-hospital-sun-yat-sen-university`)
- Registry lists this organization as a collaborator: Jinhua Central Hospital (`cardio:org-jinhua-central-hospital`)
- Registry lists this organization as a collaborator: Guangdong Provincial Hospital of Traditional Chinese Medicine (`cardio:org-guangdong-provincial-hospital-of-traditional-chinese-befb6a`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Kunming Medical University (`cardio:org-first-affiliated-hospital-of-kunming-medical-university`)
- Registry lists this organization as a collaborator: Tianjin Medical University General Hospital (`cardio:org-tianjin-medical-university-general-hospital`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)
- Registry lists this organization as a collaborator: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)
- Registry lists this organization as a collaborator: General Hospital of Ningxia Medical University (`cardio:org-general-hospital-of-ningxia-medical-university`)

## Provenance

Content hash: 0a617ff4d22bdcbb44c87c6764563dbfd064a8344567c43ffff292395e5ba5f0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
